Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1999 Nov;75(889):650–656. doi: 10.1136/pgmj.75.889.650

Overdiagnosis and overtreatment of Lyme neuroborreliosis are preventable

A Prasad 1, D Sankar 1
PMCID: PMC1741416  PMID: 10621874

Abstract

The problems of diagnosis and treatment of Lyme neuroborreliosis can be minimised by strictly following the clinical diagnostic criteria, and understanding the pitfalls of laboratory tests. The diagnosis is based solely on objective clinical findings, with serologic test results used only to confirm the diagnosis. It must be underscored that serologic testing, when ordered without regard for clinical presentation (ie, used as a screen), may be misleading due to its extremely low positive predictive value. Enzyme-linked immunosorbent assay should always be confirmed by Western blot. The cerebrospinal fluid Borrelia burgdorferi antibody index is more meaningful than simple titres of specific antibody. Polymerase chain reaction is still a research tool and should not be utilised without clinical correlation. All serologic tests and polymerase chain reaction may remain positive long after successful treatment. Overdiagnosis and overtreatment can be minimised by following these guidelines.


Keywords: Lyme disease; neuroborreliosis; Borrelia burgdorferi

Full Text

The Full Text of this article is available as a PDF (93.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbour A. G. Laboratory aspects of Lyme borreliosis. Clin Microbiol Rev. 1988 Oct;1(4):399–414. doi: 10.1128/cmr.1.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clark J. R., Carlson R. D., Sasaki C. T., Pachner A. R., Steere A. C. Facial paralysis in Lyme disease. Laryngoscope. 1985 Nov;95(11):1341–1345. [PubMed] [Google Scholar]
  3. Dattwyler R. J., Halperin J. J., Volkman D. J., Luft B. J. Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin. Lancet. 1988 May 28;1(8596):1191–1194. doi: 10.1016/s0140-6736(88)92011-9. [DOI] [PubMed] [Google Scholar]
  4. Dressler F., Whalen J. A., Reinhardt B. N., Steere A. C. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993 Feb;167(2):392–400. doi: 10.1093/infdis/167.2.392. [DOI] [PubMed] [Google Scholar]
  5. Feder H. M., Jr, Gerber M. A., Luger S. W., Ryan R. W. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis. 1992 Nov;15(5):788–793. doi: 10.1093/clind/15.5.788. [DOI] [PubMed] [Google Scholar]
  6. Finkel M. F., Halperin J. J., Finkel M. J. Nervous system Lyme borreliosis--revisited [corrected; erratum to be published]. Arch Neurol. 1992 Jan;49(1):102–107. doi: 10.1001/archneur.1992.00530250106024. [DOI] [PubMed] [Google Scholar]
  7. Halperin J. J., Krupp L. B., Golightly M. G., Volkman D. J. Lyme borreliosis-associated encephalopathy. Neurology. 1990 Sep;40(9):1340–1343. doi: 10.1212/wnl.40.9.1340. [DOI] [PubMed] [Google Scholar]
  8. Halperin J. J., Logigian E. L., Finkel M. F., Pearl R. A. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1996 Mar;46(3):619–627. [PubMed] [Google Scholar]
  9. Johnson B. J., Robbins K. E., Bailey R. E., Cao B. L., Sviat S. L., Craven R. B., Mayer L. W., Dennis D. T. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis. 1996 Aug;174(2):346–353. doi: 10.1093/infdis/174.2.346. [DOI] [PubMed] [Google Scholar]
  10. Kaplan R. F., Jones-Woodward L. Lyme encephalopathy: a neuropsychological perspective. Semin Neurol. 1997 Mar;17(1):31–37. doi: 10.1055/s-2008-1040910. [DOI] [PubMed] [Google Scholar]
  11. Karlsson M., Hovind-Hougen K., Svenungsson B., Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol. 1990 Mar;28(3):473–479. doi: 10.1128/jcm.28.3.473-479.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Keller T. L., Halperin J. J., Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology. 1992 Jan;42(1):32–42. doi: 10.1212/wnl.42.1.32. [DOI] [PubMed] [Google Scholar]
  13. Kohler J., Kern U., Kasper J., Rhese-Küpper B., Thoden U. Chronic central nervous system involvement in Lyme borreliosis. Neurology. 1988 Jun;38(6):863–867. doi: 10.1212/wnl.38.6.863. [DOI] [PubMed] [Google Scholar]
  14. Krüger H., Kohlhepp W., König S. Follow-up of antibiotically treated and untreated neuroborreliosis. Acta Neurol Scand. 1990 Jul;82(1):59–67. doi: 10.1111/j.1600-0404.1990.tb01588.x. [DOI] [PubMed] [Google Scholar]
  15. Logigian E. L., Kaplan R. F., Steere A. C. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990 Nov 22;323(21):1438–1444. doi: 10.1056/NEJM199011223232102. [DOI] [PubMed] [Google Scholar]
  16. Müllegger R. R., Millner M. M., Stanek G., Spork K. D. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study. Infection. 1991 Jul-Aug;19(4):279–283. doi: 10.1007/BF01644967. [DOI] [PubMed] [Google Scholar]
  17. Nadelman R. B., Arlin Z., Wormser G. P. Life-threatening complications of empiric ceftriaxone therapy for 'seronegative Lyme disease'. South Med J. 1991 Oct;84(10):1263–1265. doi: 10.1097/00007611-199110000-00024. [DOI] [PubMed] [Google Scholar]
  18. Nocton J. J., Bloom B. J., Rutledge B. J., Persing D. H., Logigian E. L., Schmid C. H., Steere A. C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis. 1996 Sep;174(3):623–627. doi: 10.1093/infdis/174.3.623. [DOI] [PubMed] [Google Scholar]
  19. Pachner A. R., Delaney E. The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis. Ann Neurol. 1993 Oct;34(4):544–550. doi: 10.1002/ana.410340407. [DOI] [PubMed] [Google Scholar]
  20. Pachner A. R., Duray P., Steere A. C. Central nervous system manifestations of Lyme disease. Arch Neurol. 1989 Jul;46(7):790–795. doi: 10.1001/archneur.1989.00520430086023. [DOI] [PubMed] [Google Scholar]
  21. Pachner A. R., Steere A. C. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985 Jan;35(1):47–53. doi: 10.1212/wnl.35.1.47. [DOI] [PubMed] [Google Scholar]
  22. Sigal L. H. Current recommendations for the treatment of Lyme disease. Drugs. 1992 May;43(5):683–699. doi: 10.2165/00003495-199243050-00005. [DOI] [PubMed] [Google Scholar]
  23. Sigal L. H. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med. 1990 Jun;88(6):577–581. doi: 10.1016/0002-9343(90)90520-n. [DOI] [PubMed] [Google Scholar]
  24. Steere A. C., Berardi V. P., Weeks K. E., Logigian E. L., Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis. 1990 Jun;161(6):1203–1209. doi: 10.1093/infdis/161.6.1203. [DOI] [PubMed] [Google Scholar]
  25. Sterman A. B., Nelson S., Barclay P. Demyelinating neuropathy accompanying Lyme disease. Neurology. 1982 Nov;32(11):1302–1305. doi: 10.1212/wnl.32.11.1302. [DOI] [PubMed] [Google Scholar]
  26. Treib J., Woessner R., Dobler G., Fernandez A., Holzer G., Schimrigk K. Clinical value of specific intrathecal production of antibodies. Acta Virol. 1997 Feb;41(1):27–30. [PubMed] [Google Scholar]
  27. Wormser G. P. Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination. Semin Neurol. 1997 Mar;17(1):45–52. doi: 10.1055/s-2008-1040912. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES